Oxford Textbook of Sjgren's Syndrome

Dr Elizabeth J Price is a consultant rheumatologist who has a specific interest in Sjogren's Syndrome and runs a specialist Sjogren's clinic at the Great Western Hospital in Swindon. Her interest in Sjogren's dates from her Research Fellowship at The Kennedy Institute in London where she completed an MD thesis focusing on Sjogren's syndrome. She currently focuses on extraglandular manifestations of the disease and clinical research into SS and was the lead author and driving force behind the BSR Guidelines for the management of Sjogren's syndrome. Dr Anwar R Tappuni is Reader/Honorary Consultant in Oral Medicine, Institute of Dentistry, Queen Mary University of London, UK

Section 1: Introduction 1.1: Elizabeth J. Price and Anwar R. Tappuni: Introduction 1.2: Caroline Shiboski and Troy E. Daniels: Historical background, classification and diagnostic criteria 1.3: Simon Bowman: Epidemiology and genetics of Sjoegren s Syndrome Section 2: Basic science 2.1: Onorina Berardicurti, Charlotte G. Smith, Roberto Giacomelli, Elizabeth J. Price, and Francesca Barone: Biomarkers in primary Sjoegren sSyndrome 2.2: Aurelie Ambrosi, Albin Bjoerk, and Marie Wahren-Herlenius: Autoantibodies and autoantigens in Sjoegren s Syndrome 2.3: Saba Nayar, Serena Colafrancesco, and Francesca Barone: Stromal cells in Sjoegren s Syndrome Section 3: Diagnostic investigations 3.1: Anwar R. Tappuni: Clinical assessment of salivary glands function 3.2: Benjamin Fisher: Biopsy gland biopsy procedure and histopathology 3.3: Ashok Adams: Imaging in Sjoegren s Syndrome Section 4: Head and neck manifestations and clinical management 4.1: Emily Carter: Salivary glands manifestations and management 4.2: Anwar R. Tappuni: Oral manifestations and management 4.3: Jennifer Fuller and Shakeel Shahdad: Dental related disease Section 5: Ocular manifestations and management 5.1: Nicola Roper, Pasquale Aragona, Maurizio Rolando, and Francisco C Figueiredo: Ocular Manifestations of Sjoegren s Syndrome 5.2: Nicola Roper, Pasquale Aragona, Maurizio Rolando, and Francisco C Figueiredo: A therapeutic strategy for Sjoegren s Syndrome dry eye Section 6: Systemic manifestations 6.1: Thomas J Tull, Emma Benton, and David D Cruz: Cutaneous involvement and management of Sjoegren s Syndrome 6.2: Elizabeth J. Price: Musculoskeletal disease - presentation and management 6.3: Rhys Evans and Stephen Walsh: Renal involvement in Primary Sjoegren's Syndrome 6.4: Elizabeth J. Price: Gastrointestinal Disease in Sjoegren s syndrome 6.5: Aravind Ganesh, Shane Lyons, and Gabriel Yiin: Neurological complications of Sjoegren s Syndrome 6.6: Sara Carty: Cardiovascular and Lung Manifestations of Sjoegren s Syndrome 6.7: Coziana Ciurtin and Su-Ann Yeoh: Haematological Manifestations of Sjoegren s Syndrome 6.8: Coziana Ciurtin and Su-Ann Yeoh: Fatigue in Sjoegren s Syndrome 6.9: Katie Hackett and Helen Cartner: Non-pharmacological interventions for the management of Fatigue and Constitutional Symptoms in Sjoegren s Syndrome 6.1: Roberta Priori, Antonina Minniti, and Serena Colafrancesco: Gynaecologic and obstetric aspects in Sjoegren s Syndrome 6.11: Saad Rassam: Sjoegren s Syndrome Associated Lymphoma Section 7: Juvenile and young adult 7.1: William D. Renton, Elizabeth J. Price, and A.V. Ramanan: Juvenile and young adult onset Sjoegren s Syndrome Section 8: Sjogren s mimics and overlaps 8.1: Nurhan Sutcliffe: Mimics of Sjoegren s Syndrome 8.2: Nurhan Sutcliffe and Arabella Waller: Sjoegren s Syndrome overlaps Section 9: Experimental treatments, emerging therapies and the future 9.1: Benjamin Fisher: Experimental therapies in primary Sjoegren s Syndrome 9.2: Elizabeth J. Price and Alan Baer: Sjoegren s Syndrome Summary of Clinical Management